Delves into a controversial animal experimentation case, ethical considerations, impacts of activism on scientific communities, and the role of scientists in public discussions.
Explores the selection and rationale of preclinical animal models in drug development, emphasizing the 10 to 15-year path to a marketed small-molecule drug.
